Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Sensus Healthcare, Inc.SRTS · Entity 7142 | CHIEF OPERATING OFFICER | March 09, 2022 | March 10, 2022 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Sensus Healthcare, Inc.
Report date March 09, 2022 · Filed March 10, 2022
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 3,546 |
Ending reported balance
After 2022-03-09 transaction · row 2
2 source rows · reconciled sequenceRow 1 · 2022-03-09 · Exercise / conversion · Acquired 10,000 · Balance 13,546 Row 2 · 2022-03-09 · Sale · Disposed 10,000 · Balance 3,546 F1: This represents the average price per share. The shares were sold from prices ranging from $10.04 to $10.42. |
| Employee Stock Options (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $5.55 · Expires 2028-01-25 | Direct | 0 |
Reported balance
After 2022-03-09 transaction · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · 2022-03-09 · Exercise / conversion · Disposed 10,000 · Balance 0 F2: The options vested in four equal annual installments beginning on January 25, 2019. |
Filing footnotes · ownership attribution and instrument terms
F1: This represents the average price per share. The shares were sold from prices ranging from $10.04 to $10.42.
F2: The options vested in four equal annual installments beginning on January 25, 2019.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| March 09, 2022 Filed Mar 10, 2022 16:06 UTC | Sensus Healthcare, Inc. SRTS · Entity 7142 | Exercise / conversionEmployee Stock Options (right to buy) · Derivative | 10,000 | $0.00 Strike: $5.55 | $0.00 |
DisclosureSEC source: 0001415889-22-002820 · form4-03102022_080316.xml · derivative · entry 3 Soro Nicolas · CIK 0001800450 · CHIEF OPERATING OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 10,000 shares Expires 2028-01-25 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The options vested in four equal annual installments beginning on January 25, 2019. Read SEC document |
| March 09, 2022 Filed Mar 10, 2022 16:06 UTC | Sensus Healthcare, Inc. SRTS · Entity 7142 | SaleCommon Stock | 10,000 | $10.20 | $102,000.00 |
DisclosureSEC source: 0001415889-22-002820 · form4-03102022_080316.xml · nonDerivative · entry 2 Soro Nicolas · CIK 0001800450 · CHIEF OPERATING OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,546 F1 · price: This represents the average price per share. The shares were sold from prices ranging from $10.04 to $10.42. Read SEC document |
| March 09, 2022 Filed Mar 10, 2022 16:06 UTC | Sensus Healthcare, Inc. SRTS · Entity 7142 | Exercise / conversionCommon Stock | 10,000 | $5.55 | $55,500.00 |
DisclosureSEC source: 0001415889-22-002820 · form4-03102022_080316.xml · nonDerivative · entry 1 Soro Nicolas · CIK 0001800450 · CHIEF OPERATING OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,546 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 03, 2022 Filed Mar 10, 2022 16:05 UTC | Sensus Healthcare, Inc. SRTS · Entity 7142 | Tax withholdingCommon Stock | 742 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-22-002818 · form4-03102022_080355.xml · nonDerivative · entry 1 Soro Nicolas · CIK 0001800450 · CHIEF OPERATING OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,546 Read SEC document |
| February 09, 2021 Filed Apr 27, 2021 17:57 UTC | Sensus Healthcare, Inc. SRTS · Entity 7142 | Tax withholdingCommon Stock | 742 | $3.75 | $2,782.50 |
DisclosureSEC source: 0001415889-21-002122 · form4-04272021_100439.xml · nonDerivative · entry 1 Soro Nicolas · CIK 0001800450 · CHIEF OPERATING OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,788 F1 · shares: Represents shares withheld to pay the reporting person's withholding tax obligation arising solely in connection with the vesting of restricted stock. Transaction is being reported late as a result of administrative oversight. Read SEC document |
| February 01, 2020 Filed Apr 27, 2021 18:00 UTC | Sensus Healthcare, Inc. SRTS · Entity 7142 | GrantCommon Stock | 10,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-21-002124 · form5-04272021_110422.xml · nonDerivative · entry 1 Soro Nicolas · CIK 0001800450 · CHIEF OPERATING OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,030 F1 · shares: Represents 10,000 shares of restricted stock granted to the reporting person pursuant to the Sensus Healthcare, Inc. 2017 Equity Incentive Plan which will vest in four equal annual installments beginning on the first anniversary of the date of grant. Transaction is being reported late as a result of administrative oversight. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.